have led investments in more than 90 companies and have an established track record of working closely with management teams in early stage enterprises. With strong operating backgrounds, the partners have co-founded 16 companies and served as incubating Chief Executive for 9 new enterprises in a broad range of biotechnology and medical device sectors. These early stage companies have become substantial businesses in their industry segments and have generated superior investment returns. In addition, the partners have significant biomedical and life science industry operating experience, and extensive research training from premier institutions including Harvard Medical School, Memorial Sloan Kettering Cancer Center, UC Berkeley, UCSF Medical School, University of Pennsylvania, and the Whitehead Institute/MIT.